Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

<p><strong>Objectives:</strong> Recruitment to pragmatic trials is often difficult, and little is known about factors associated with key participation and treatment decisions. These were explored in the Prostate cancer testing and Treatment (ProtecT) study.</p> <...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Donovan, JL, Opmeer, B, Young, GJ, Mills, N, Martin, RM, Lane, JA, Metcalfe, C, Peters, TJ, Davis, M, Turner, EL, Walsh, E, Neal, DE, Hamdy, FC, ProtecT Study Group
Ձևաչափ:	Journal article
Լեզու:	English
Հրապարակվել է:	Elsevier 2019

Նմանատիպ նյութեր

A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
‌: Donovan, JL, և այլն
Հրապարակվել է: (2017)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
‌: J. Donovan, և այլն
Հրապարակվել է: (2003-01-01)

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
‌: S. Sanghera, և այլն
Հրապարակվել է: (2020-10-01)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
‌: Young, GJ, և այլն
Հրապարակվել է: (2017)

Addressing patient treatment preferences at trial recruitment.
‌: Mills, N, և այլն
Հրապարակվել է: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials
‌: Mills, N, և այլն
Հրապարակվել է: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials.
‌: Mills, N, և այլն
Հրապարակվել է: (2011)

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
‌: Lane, A, և այլն
Հրապարակվել է: (2016)

Factors distinguishing general practitioners who more readily participated in a large randomized trial were identified.
‌: Down, L, և այլն
Հրապարակվել է: (2009)

Addressing patient treatment preferences at trial recruitment
‌: Mills Nicola, և այլն
Հրապարակվել է: (2011-12-01)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
‌: Donovan, J, և այլն
Հրապարակվել է: (2003)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
‌: Harrison, S, և այլն
Հրապարակվել է: (2020)

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
‌: Rooshenas, L, և այլն
Հրապարակվել է: (2018)

A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study).
‌: Mills, N, և այլն
Հրապարակվել է: (2006)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
‌: Turner, E, և այլն
Հրապարակվել է: (2011)

Radiotherapy for prostate cancer: is it 'what you do' or 'the way that you do it'? A UK perspective on technique and quality assurance.
‌: Mason, MD, և այլն
Հրապարակվել է: (2016)

Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group.
‌: Metcalfe, C, և այլն
Հրապարակվել է: (2008)

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of participatory and informed consent (PIC)
‌: Wade, J, և այլն
Հրապարակվել է: (2017)

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
‌: Walsh, E, և այլն
Հրապարակվել է: (2016)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
‌: Avery, K, և այլն
Հրապարակվել է: (2007)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
‌: Down, L, և այլն
Հրապարակվել է: (2011)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
‌: Avery, K, և այլն
Հրապարակվել է: (2008)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
‌: Macefield, R, և այլն
Հրապարակվել է: (2009)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
‌: Down, L, և այլն
Հրապարակվել է: (2011)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
‌: Lane, J, և այլն
Հրապարակվել է: (2010)

Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
‌: Hamdy, FC, և այլն
Հրապարակվել է: (2023)

ProDiet: A phase II randomized placebo-controlled trial of green tea catechins and lycopene in men at increased risk of prostate cancer
‌: Lane, JA, և այլն
Հրապարակվել է: (2018)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
‌: Collin, S, և այլն
Հրապարակվել է: (2009)

Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial
‌: Martin, RM, և այլն
Հրապարակվել է: (2018)

Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer
‌: Donovan, J, և այլն
Հրապարակվել է: (2016)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
‌: Hamdy, F, և այլն
Հրապարակվել է: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
‌: Lane, J, և այլն
Հրապարակվել է: (2007)

Understanding and improving recruitment to randomised controlled trials: Qualitative research approaches.
‌: Elliott, D, և այլն
Հրապարակվել է: (2017)

Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received
‌: Neal, D, և այլն
Հրապարակվել է: (2019)

Elucidation of Clathrin-Mediated Endocytosis in Tetrahymena Reveals an Evolutionarily Convergent Recruitment of Dynamin.
Հրապարակվել է: (2005-11-01)

Elucidation of clathrin-mediated endocytosis in tetrahymena reveals an evolutionarily convergent recruitment of dynamin.
‌: Nels C Elde, և այլն
Հրապարակվել է: (2005-11-01)

A review of reporting of participant recruitment and retention in RCTs in six major journals
‌: Tomlin Zelda, և այլն
Հրապարակվել է: (2009-07-01)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
‌: Simpkin, A, և այլն
Հրապարակվել է: (2013)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
‌: Rosario, D, և այլն
Հրապարակվել է: (2008)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
‌: Collin, S, և այլն
Հրապարակվել է: (2009)